Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1186/1476-4598-5-67.

Title:
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma | Molecular Cancer
Description:
Background Recently, a small population of cancer stem cells in adult and pediatric brain tumors has been identified. Some evidence has suggested that CD133 is a marker for a subset of leukemia and glioblastoma cancer stem cells. Especially, CD133 positive cells isolated from human glioblastoma may initiate tumors and represent novel targets for therapeutics. The gene expression and the drug resistance property of CD133 positive cancer stem cells, however, are still unknown. Results In this study, by FACS analysis we determined the percentage of CD133 positive cells in three primary cultured cell lines established from glioblastoma patients 10.2%, 69.7% and 27.5%, respectively. We also determined the average mRNA levels of markers associated with neural precursors. For example, CD90, CD44, CXCR4, Nestin, Msi1 and MELK mRNA on CD133 positive cells increased to 15.6, 5.7, 337.8, 21.4, 84 and 1351 times, respectively, compared to autologous CD133 negative cells derived from cell line No. 66. Additionally, CD133 positive cells express higher levels of BCRP1 and MGMT mRNA, as well as higher mRNA levels of genes that inhibit apoptosis. Furthermore, CD133 positive cells were significantly resistant to chemotherapeutic agents including temozolomide, carboplatin, paclitaxel (Taxol) and etoposide (VP16) compared to autologous CD133 negative cells. Finally, CD133 expression was significantly higher in recurrent GBM tissue obtained from five patients as compared to their respective newly diagnosed tumors. Conclusion Our study for the first time provided evidence that CD133 positive cancer stem cells display strong capability on tumor
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {πŸ“š}

  • Science
  • Education
  • Health & Fitness

Content Management System {πŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {πŸ’Έ}

The income method remains a mystery to us.

Earning money isn't the goal of every website; some are designed to offer support or promote social causes. People have different reasons for creating websites. This might be one such reason. Link.springer.com might be earning cash quietly, but we haven't detected the monetization method.

Keywords {πŸ”}

cells, stem, cancer, positive, cell, tumor, expression, pubmed, article, google, scholar, cas, resistance, negative, glioblastoma, primary, drug, tissue, tumors, levels, autologous, genes, medium, compared, cultured, neural, apoptosis, found, mrna, higher, temozolomide, chemotherapy, brain, bcrp, protein, normal, bcl, data, population, patients, derived, recurrent, dna, gene, study, lines, chemotherapeutic, agents, capacity, figure,

Topics {βœ’οΈ}

real-time quantitative rt-pcr cedars-sinai medical center open access article schering-plough research institute article download pdf pre-coated chamber slides o6-alkylguanine dna alkyltransferase 10% fbs/dmem/f-12 medium fbs/dmem/f-12 medium pe-ant-mouse igg1 cell-membrane protein cd133 brain-tumour drug resistance isotype control-matched mab cancer stem cell neural stem cells cancer stem cells dna-mismatch repair genes cancer cell death active dna-repair capacity isolated cd133 positive drug-transporter protein bcrp1 abc transporter bcrp1/abcg2 isolate cd133 positive low bcl-2/bax ratio central nervous system cd133 positive cell aml progenitors tumour stem cells cd133 positive cells mammalian bmi-1 proto-oncogene pro-apoptotic gene bax leukemic stem cells glioblastoma stem cells normal stem cells hematopoietic stem cells autologous cd133- cells promoter methylation therapeutic window rabbit polyclonal igg real-time pcr cancerous stem cells leukaemic stem cells haematopoietic stem cells mgmt-mediated dna repair acute myeloid leukemia high-grade gliomas [17] high-grade gliomas cd133 negative cells privacy choices/manage cookies stem cell populations

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
         description:Recently, a small population of cancer stem cells in adult and pediatric brain tumors has been identified. Some evidence has suggested that CD133 is a marker for a subset of leukemia and glioblastoma cancer stem cells. Especially, CD133 positive cells isolated from human glioblastoma may initiate tumors and represent novel targets for therapeutics. The gene expression and the drug resistance property of CD133 positive cancer stem cells, however, are still unknown. In this study, by FACS analysis we determined the percentage of CD133 positive cells in three primary cultured cell lines established from glioblastoma patients 10.2%, 69.7% and 27.5%, respectively. We also determined the average mRNA levels of markers associated with neural precursors. For example, CD90, CD44, CXCR4, Nestin, Msi1 and MELK mRNA on CD133 positive cells increased to 15.6, 5.7, 337.8, 21.4, 84 and 1351 times, respectively, compared to autologous CD133 negative cells derived from cell line No. 66. Additionally, CD133 positive cells express higher levels of BCRP1 and MGMT mRNA, as well as higher mRNA levels of genes that inhibit apoptosis. Furthermore, CD133 positive cells were significantly resistant to chemotherapeutic agents including temozolomide, carboplatin, paclitaxel (Taxol) and etoposide (VP16) compared to autologous CD133 negative cells. Finally, CD133 expression was significantly higher in recurrent GBM tissue obtained from five patients as compared to their respective newly diagnosed tumors. Our study for the first time provided evidence that CD133 positive cancer stem cells display strong capability on tumor's resistance to chemotherapy. This resistance is probably contributed by the CD133 positive cell with higher expression of on BCRP1 and MGMT, as well as the anti-apoptosis protein and inhibitors of apoptosis protein families. Future treatment should target this small population of CD133 positive cancer stem cells in tumors to improve the survival of brain tumor patients.
         datePublished:2006-12-02T00:00:00Z
         dateModified:2006-12-02T00:00:00Z
         pageStart:1
         pageEnd:12
         license:https://creativecommons.org/licenses/by/2.0
         sameAs:https://doi.org/10.1186/1476-4598-5-67
         keywords:
            Cancer Stem Cell
            Neural Stem Cell
            Temozolomide
            Side Population
            CD133 Positive Cell
            Cancer Research
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1476-4598-5-67/MediaObjects/12943_2006_Article_199_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1476-4598-5-67/MediaObjects/12943_2006_Article_199_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1476-4598-5-67/MediaObjects/12943_2006_Article_199_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1476-4598-5-67/MediaObjects/12943_2006_Article_199_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1476-4598-5-67/MediaObjects/12943_2006_Article_199_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1476-4598-5-67/MediaObjects/12943_2006_Article_199_Fig6_HTML.jpg
         isPartOf:
            name:Molecular Cancer
            issn:
               1476-4598
            volumeNumber:5
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Gentao Liu
               affiliation:
                     name:Cedars-Sinai Medical Center
                     address:
                        name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                        type:PostalAddress
                     type:Organization
                     name:Cedars-Sinai Medical Center/David Geffen School of Medicine at UCLA
                     address:
                        name:Division of Hematology/Oncology, Cedars-Sinai Medical Center/David Geffen School of Medicine at UCLA, Los Angeles, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiangpeng Yuan
               affiliation:
                     name:Cedars-Sinai Medical Center
                     address:
                        name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Zhaohui Zeng
               affiliation:
                     name:Cedars-Sinai Medical Center
                     address:
                        name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Patrizia Tunici
               affiliation:
                     name:Cedars-Sinai Medical Center
                     address:
                        name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hiushan Ng
               affiliation:
                     name:Cedars-Sinai Medical Center
                     address:
                        name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Iman R Abdulkadir
               affiliation:
                     name:Cedars-Sinai Medical Center
                     address:
                        name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lizhi Lu
               affiliation:
                     name:Cedars-Sinai Medical Center
                     address:
                        name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                        type:PostalAddress
                     type:Organization
                     name:Zhejiang Academy of Agricultural Sciences
                     address:
                        name:Institute of Animal Husbandry and Veterinary Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, P.R. China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Dwain Irvin
               affiliation:
                     name:Cedars-Sinai Medical Center
                     address:
                        name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Keith L Black
               affiliation:
                     name:Cedars-Sinai Medical Center
                     address:
                        name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:John S Yu
               affiliation:
                     name:Cedars-Sinai Medical Center
                     address:
                        name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                        type:PostalAddress
                     type:Organization
                     name:
                     address:
                        name:Los Angeles, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
      description:Recently, a small population of cancer stem cells in adult and pediatric brain tumors has been identified. Some evidence has suggested that CD133 is a marker for a subset of leukemia and glioblastoma cancer stem cells. Especially, CD133 positive cells isolated from human glioblastoma may initiate tumors and represent novel targets for therapeutics. The gene expression and the drug resistance property of CD133 positive cancer stem cells, however, are still unknown. In this study, by FACS analysis we determined the percentage of CD133 positive cells in three primary cultured cell lines established from glioblastoma patients 10.2%, 69.7% and 27.5%, respectively. We also determined the average mRNA levels of markers associated with neural precursors. For example, CD90, CD44, CXCR4, Nestin, Msi1 and MELK mRNA on CD133 positive cells increased to 15.6, 5.7, 337.8, 21.4, 84 and 1351 times, respectively, compared to autologous CD133 negative cells derived from cell line No. 66. Additionally, CD133 positive cells express higher levels of BCRP1 and MGMT mRNA, as well as higher mRNA levels of genes that inhibit apoptosis. Furthermore, CD133 positive cells were significantly resistant to chemotherapeutic agents including temozolomide, carboplatin, paclitaxel (Taxol) and etoposide (VP16) compared to autologous CD133 negative cells. Finally, CD133 expression was significantly higher in recurrent GBM tissue obtained from five patients as compared to their respective newly diagnosed tumors. Our study for the first time provided evidence that CD133 positive cancer stem cells display strong capability on tumor's resistance to chemotherapy. This resistance is probably contributed by the CD133 positive cell with higher expression of on BCRP1 and MGMT, as well as the anti-apoptosis protein and inhibitors of apoptosis protein families. Future treatment should target this small population of CD133 positive cancer stem cells in tumors to improve the survival of brain tumor patients.
      datePublished:2006-12-02T00:00:00Z
      dateModified:2006-12-02T00:00:00Z
      pageStart:1
      pageEnd:12
      license:https://creativecommons.org/licenses/by/2.0
      sameAs:https://doi.org/10.1186/1476-4598-5-67
      keywords:
         Cancer Stem Cell
         Neural Stem Cell
         Temozolomide
         Side Population
         CD133 Positive Cell
         Cancer Research
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1476-4598-5-67/MediaObjects/12943_2006_Article_199_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1476-4598-5-67/MediaObjects/12943_2006_Article_199_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1476-4598-5-67/MediaObjects/12943_2006_Article_199_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1476-4598-5-67/MediaObjects/12943_2006_Article_199_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1476-4598-5-67/MediaObjects/12943_2006_Article_199_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2F1476-4598-5-67/MediaObjects/12943_2006_Article_199_Fig6_HTML.jpg
      isPartOf:
         name:Molecular Cancer
         issn:
            1476-4598
         volumeNumber:5
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Gentao Liu
            affiliation:
                  name:Cedars-Sinai Medical Center
                  address:
                     name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                     type:PostalAddress
                  type:Organization
                  name:Cedars-Sinai Medical Center/David Geffen School of Medicine at UCLA
                  address:
                     name:Division of Hematology/Oncology, Cedars-Sinai Medical Center/David Geffen School of Medicine at UCLA, Los Angeles, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiangpeng Yuan
            affiliation:
                  name:Cedars-Sinai Medical Center
                  address:
                     name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Zhaohui Zeng
            affiliation:
                  name:Cedars-Sinai Medical Center
                  address:
                     name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Patrizia Tunici
            affiliation:
                  name:Cedars-Sinai Medical Center
                  address:
                     name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hiushan Ng
            affiliation:
                  name:Cedars-Sinai Medical Center
                  address:
                     name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Iman R Abdulkadir
            affiliation:
                  name:Cedars-Sinai Medical Center
                  address:
                     name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lizhi Lu
            affiliation:
                  name:Cedars-Sinai Medical Center
                  address:
                     name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                     type:PostalAddress
                  type:Organization
                  name:Zhejiang Academy of Agricultural Sciences
                  address:
                     name:Institute of Animal Husbandry and Veterinary Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, P.R. China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Dwain Irvin
            affiliation:
                  name:Cedars-Sinai Medical Center
                  address:
                     name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Keith L Black
            affiliation:
                  name:Cedars-Sinai Medical Center
                  address:
                     name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:John S Yu
            affiliation:
                  name:Cedars-Sinai Medical Center
                  address:
                     name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
                     type:PostalAddress
                  type:Organization
                  name:
                  address:
                     name:Los Angeles, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Molecular Cancer
      issn:
         1476-4598
      volumeNumber:5
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Cedars-Sinai Medical Center
      address:
         name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
         type:PostalAddress
      name:Cedars-Sinai Medical Center/David Geffen School of Medicine at UCLA
      address:
         name:Division of Hematology/Oncology, Cedars-Sinai Medical Center/David Geffen School of Medicine at UCLA, Los Angeles, USA
         type:PostalAddress
      name:Cedars-Sinai Medical Center
      address:
         name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
         type:PostalAddress
      name:Cedars-Sinai Medical Center
      address:
         name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
         type:PostalAddress
      name:Cedars-Sinai Medical Center
      address:
         name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
         type:PostalAddress
      name:Cedars-Sinai Medical Center
      address:
         name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
         type:PostalAddress
      name:Cedars-Sinai Medical Center
      address:
         name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
         type:PostalAddress
      name:Cedars-Sinai Medical Center
      address:
         name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
         type:PostalAddress
      name:Zhejiang Academy of Agricultural Sciences
      address:
         name:Institute of Animal Husbandry and Veterinary Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, P.R. China
         type:PostalAddress
      name:Cedars-Sinai Medical Center
      address:
         name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
         type:PostalAddress
      name:Cedars-Sinai Medical Center
      address:
         name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
         type:PostalAddress
      name:Cedars-Sinai Medical Center
      address:
         name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
         type:PostalAddress
      name:
      address:
         name:Los Angeles, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Gentao Liu
      affiliation:
            name:Cedars-Sinai Medical Center
            address:
               name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
               type:PostalAddress
            type:Organization
            name:Cedars-Sinai Medical Center/David Geffen School of Medicine at UCLA
            address:
               name:Division of Hematology/Oncology, Cedars-Sinai Medical Center/David Geffen School of Medicine at UCLA, Los Angeles, USA
               type:PostalAddress
            type:Organization
      name:Xiangpeng Yuan
      affiliation:
            name:Cedars-Sinai Medical Center
            address:
               name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
               type:PostalAddress
            type:Organization
      name:Zhaohui Zeng
      affiliation:
            name:Cedars-Sinai Medical Center
            address:
               name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
               type:PostalAddress
            type:Organization
      name:Patrizia Tunici
      affiliation:
            name:Cedars-Sinai Medical Center
            address:
               name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
               type:PostalAddress
            type:Organization
      name:Hiushan Ng
      affiliation:
            name:Cedars-Sinai Medical Center
            address:
               name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
               type:PostalAddress
            type:Organization
      name:Iman R Abdulkadir
      affiliation:
            name:Cedars-Sinai Medical Center
            address:
               name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
               type:PostalAddress
            type:Organization
      name:Lizhi Lu
      affiliation:
            name:Cedars-Sinai Medical Center
            address:
               name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
               type:PostalAddress
            type:Organization
            name:Zhejiang Academy of Agricultural Sciences
            address:
               name:Institute of Animal Husbandry and Veterinary Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, P.R. China
               type:PostalAddress
            type:Organization
      name:Dwain Irvin
      affiliation:
            name:Cedars-Sinai Medical Center
            address:
               name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
               type:PostalAddress
            type:Organization
      name:Keith L Black
      affiliation:
            name:Cedars-Sinai Medical Center
            address:
               name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
               type:PostalAddress
            type:Organization
      name:John S Yu
      affiliation:
            name:Cedars-Sinai Medical Center
            address:
               name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
               type:PostalAddress
            type:Organization
            name:
            address:
               name:Los Angeles, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
      name:Division of Hematology/Oncology, Cedars-Sinai Medical Center/David Geffen School of Medicine at UCLA, Los Angeles, USA
      name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
      name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
      name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
      name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
      name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
      name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
      name:Institute of Animal Husbandry and Veterinary Science, Zhejiang Academy of Agricultural Sciences, Hangzhou, P.R. China
      name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
      name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
      name:Maxine Dunitz Neurosurgical Institute, Cedars-Sinai Medical Center, Los Angeles, USA
      name:Los Angeles, USA

External Links {πŸ”—}(155)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {πŸ“¦}

  • Crossref

4.77s.